Brett Sutton
Overview
Explore the profile of Brett Sutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szanyi J, Price D, Carville K, Batty M, Yallop S, Nicholson S, et al.
Commun Dis Intell (2018)
. 2024 Aug;
48.
PMID: 39165016
Objectives: To compare serological evidence of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with linked coronavirus disease 2019 (COVID-19) case notification data in Victoria, Australia, and to determine...
2.
Skerritt J, Tucek-Szabo C, Sutton B, Nolan T
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793779
mRNA-lipid nanoparticle (LNP) medicinal products can be considered a platform technology because the development process is similar for different diseases and conditions, with similar noncoding mRNA sequences and lipid nanoparticles...
3.
Wong E, Sutton B, McLaughlin T, McGrath C, Baptista M, Stripp A, et al.
Lancet Reg Health West Pac
. 2023 Nov;
39:100900.
PMID: 37928002
Background: We describe COVID-19 first and second vaccine uptake across Local Government Areas (LGAs) in Victoria using southeast metropolitan Melbourne catchment as a case study. We explore key policy and...
4.
Van Heer C, Majumdar S, Parta I, Martinie M, Dawson R, West D, et al.
Lancet Reg Health West Pac
. 2023 Nov;
41:100917.
PMID: 37927380
Background: Oral Antiviral (OAV) COVID-19 treatments are widely used, but evidence for their effectiveness against the Omicron variant in higher risk, vaccinated individuals is limited. Methods: Retrospective study of two...
5.
Scott N, Abeysuriya R, Delport D, Sacks-Davis R, Nolan J, West D, et al.
BMC Public Health
. 2023 May;
23(1):988.
PMID: 37237343
Background: Policy responses to COVID-19 in Victoria, Australia over 2020-2021 have been supported by evidence generated through mathematical modelling. This study describes the design, key findings, and process for policy...
6.
Rowe S, Leder K, Dyson K, Sundaresan L, Wollersheim D, Lynch B, et al.
Med J Aust
. 2022 Nov;
218(1):33-39.
PMID: 36377203
Objectives: To assess associations between SARS-CoV-2 infection and the incidence of hospitalisation with selected respiratory and non-respiratory conditions in a largely SARS-CoV-2 vaccine-naïve population . Design, Setting, Participants: Self-control case...
7.
Davis A, Munari S, Doyle J, Sutton B, Cheng A, Hellard M, et al.
BMC Public Health
. 2022 Sep;
22(1):1806.
PMID: 36138365
Background: A key feature of the global public health response to contain and slow the spread of COVID-19 has been community-based quarantine and self-isolation. As part of The Optimise Study,...
8.
Trauer J, Lydeamore M, Dalton G, Pilcher D, Meehan M, McBryde E, et al.
Nat Commun
. 2021 Nov;
12(1):6266.
PMID: 34725323
During 2020, Victoria was the Australian state hardest hit by COVID-19, but was successful in controlling its second wave through aggressive policy interventions. We calibrated a detailed compartmental model of...
9.
10.
Lane C, Sherry N, Porter A, Duchene S, Horan K, Andersson P, et al.
Lancet Public Health
. 2021 Jul;
6(8):e547-e556.
PMID: 34252365
Background: A cornerstone of Australia's ability to control COVID-19 has been effective border control with an extensive supervised quarantine programme. However, a rapid recrudescence of COVID-19 was observed in the...